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Abstract
Background: Cardiopulmonary bypass (CPB) with aortic cross-clamping and cardioplegic arrest
remains the method of choice for patients requiring standard myocardial revascularization.
Therefore, very high-risk patients presenting with acute coronary syndrome, unstable angina, onset
of cardiac decompensation and requiring emergency multiple myocardial revascularization, can
have a poor outcome. The on-pump beating heart technique can reduce the mortality and the
morbidity in such a selected group of patients and this report describes our clinical experience.
Methods: Out of 290 patients operated for CABG from January 2005 to January 2006, 25 (8.6%)
selected high-risk patients suffering from life threatening coronary syndrome (mean age 69 ± 7
years) and requiring emergency multiple myocardial revascularization, underwent on-pump beating
heart surgery. The mean pre-operative left ventricle ejection fraction (LVEF) was 27 ± 8%. The
majority of them (88%) suffered of tri-vessel coronary disease and 6 (24%) had a left main stump
disease. Nine patients (35%) were on severe cardiac failure and seven among them (28%) received
a pre-operative intra-aortic balloon pump. The pre-operative EuroScore rate was equal or above
8 in 18 patients (73%).
Results: All patients underwent on-pump-beating heart coronary revascularization. The mean
number of graft/patient was 2.9 ± 0.6 and the internal mammary artery was used in 23 patients
(92%). The mean CPB time was 84 ± 19 minutes. Two patients died during the recovery stay in the
intensive care unit, and there were no postoperative myocardial infarctions between the survivors.
Eight patients suffered of transitorily renal failure and 1 patient developed a sternal wound
infection. The mean hospital stay was 12 ± 7 days. The follow-up was complete for all 23 patients
survived at surgery and the mean follow-up time was 14 ± 5 months. One patient died during the
follow-up for cardiac arrest and 2 patients required an implantable cardiac defibrillator. One year
after surgery they all had a standard trans-thoracic echocardiogram showing a mean LVEF rate of
36 ± 11.8%.
Conclusion: Standard on-pump arrested heart coronary surgery has higher mortality and
morbidity in emergencies. The on-pump beating heart myocardial revascularization seems to be a
valid alternative for the restricted and selected cohort of patients suffering from life threatening
coronary syndrome and requiring multiple emergency CABG.
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Use of cardiopulmonary bypass (CPB) with aortic cross-
clamping and cardioplegic arrest remains the method of
choice for patients requiring standard myocardial revascu-
larization. This technique, which is used routinely world-
wide to perform standard coronary artery bypass grafting
(CABG), is still linked to several side-effects mostly due to
the use of aortic cross-clamping, cardioplegic heart arrest
and CPB, especially in emergency cases. During the last
twenty years many efforts have been undertaken to reduce
the incidence of major intraoperative and postoperative
complications related to the procedure. In particular,
shorter CPB circuits and newer cardioplegic arrests have
been developed coupled with the beating-heart coronary
surgery and the so-called "no touch technique" for vessel
manipulation.
Despite low-risk patients requiring standard CABG having
a poor risk to develop intraoperative and postoperative
complications from the use of CPB and cardioplegic
arrest, the subgroup of high-risk patients suffering from
acute coronary syndrome with unstable angina and severe
cardiac failure is extremely sensitive to emergency surgery:
clinical and experimental trials present in literature con-
firm that use of CPB and cardioplegic arrest are strictly
related with a multitude of pathogenic mechanisms
responsible for the higher intraoperative and postopera-
tive risk [1-3], but, on the other hand, patients suffering
from unstable angina and undergoing emergency CABG
are expected to derive the greatest benefits from multiple
myocardial revascularization. In terms of left ventricular
ejection fraction (LVEF), for example, an improvement
will be expected if the ischemic and the hibernate myocar-
dium could be restored after surgery and, moreover, some
trials have already demonstrated that there are significant
survival benefits for patients undergoing CABG and suf-
fering from acute left ventricular dysfunction (preopera-
tive LVEF<30%) due to extensive coronary disease [4,5].
To avoid the use of CPB, aortic cross-clamping and cardi-
oplegic arrest, the off-pump coronary artery bypass graft-
ing (OPCAB) technique was developed in the nineties
with the specific purpose of reducing the mortality and
the morbidity in high-risk and low-risk patients [6-8].
Unfortunately, during the extensive surgical manipula-
tion and heart displacement necessary to perform multi-
ple distal anastomoses, the OPCAB technique can cause
episodes of transitory hemodynamic instability that could
lead to secondary critical low coronary artery diastolic
blood flow followed by severe complications or death.
The on-pump beating heart coronary surgery represents a
merge of standard on-pump surgery and OPCAB tech-
nique. The absence of cardioplegic arrest coupled with the
hemodynamic stability guaranteed during extensive heart
manipulation, are the biggest benefits coming from this
technique, especially in cases of unstable high risk
patients. In the present study we describe our clinical
experience with the on-pump beating heart coronary sur-
gery for emergency multiple myocardial revascularization.
Methods
From January 2005 to January 2006, out of 290 consecu-
tive patients operated for isolated CABG in our depart-
ment, 25 selected high-risk patients presenting with onset
of acute coronary syndrome, unstable angina, signs of
myocardial infarction and/or severe myocardial dysfunc-
tion, and not suitable for primary angioplasty or throm-
bolysis, were operated for emergency multiple myocardial
revascularization using the on-pump beating heart coro-
nary surgery technique. The major selection criteria were
the absence of previous cardiac operation and the surgical
myocardial revascularization as the lone suitable treat-
ment for the life threatening coronary syndrome and/or
initial myocardial infarction. The preoperative patients'
characteristics are listed in Table 1. The mean age was 69
± 7 years and 18 patients were male. The atherosclerosis
risk factors distribution was the following: 65% active
smokers, 56% suffering from systemic hypertension and
70% under treatment for hypercholesterolemia. A posi-
tive anamnesis of previous acute myocardial infarction
was given in 13 cases (53%) and 9 patients (35%) were
hospitalized for acute myocardial infarction during the
week before surgery. Among them, nine patients (35%)
developed signs of severe low cardiac output during or
immediately after the cardiac angiogram, seven patients
required a pre-operative intra-aortic balloon pump (IABP)
implantation in the catheterization laboratory, and an
emergency intubation with mechanical ventilation was
necessary five times. All patients underwent a preoperative
cardiac assessment with a chest X-ray, an EKG, a standard
coronary angiogram and a trans-thoracic echocardiogram.
Echocardiografically, the mean left ventricle ejection frac-
tion (LVEF) rate was 27 ± 8%. Onsets of mitral valve dys-
function or regurgitation with left ventricular dilatation
and/or focal dysfunction were important criteria for emer-
gency coronary revascularization and pre-operative intra-
aortic balloon pump positioning if other therapies were
contraindicated (i.e. thrombolysis and primary angi-
oplasty). Patients presenting with severe chest pain and/or
low cardiac output were immediately treated with anti-
platelet drugs, intra-venous heparin or nitroglycerin infu-
sion, and/or inotropic drugs (Dobutamine, Noradrena-
line) depending on the hemodynamic stability. The
coronary angiogram showed that twenty two patients
(88%) suffered from severe tri-vessel coronary artery dis-
ease and the left main stump disease was diagnosed 6
times.Page 2 of 6
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in 18 patients (73%) (Table 2) and all patients who sur-
vived surgery were followed up with an echocardiogram
and a complete clinical examination one year after the
surgery. The follow-up was 100% complete.
Surgical technique
Patients were prepared for surgery following the conven-
tional guidelines for CABG and a trans-esophageal
echocardiogram was routinely performed intraopera-
tively. Through a median sternotomy, all patients were
cannulated in the standard way. On the beating heart,
normo-thermia and full cardiopulmonary bypass (CPB),
the grafts were distally anastomized to the coronary arter-
ies using the CTS Axius Guidant Stabilizer system
(Guidant Corporation, Santa Clara, CA, USA), beginning
from the left mammary artery on the left anterior descend-
ing coronary artery. Intra-coronary shunts by Medtronic
(Medtronic Inc. Minneapolis, MN, USA) were used when
needed. The venous proximal anastomosis was performed
immediately after each distal anastomosis directly to the
ascending aorta using an aortic side-clamp and a cardio
punch.
Results
All 25 high-risk patients were operated for emergency
multiple myocardial revascularization using the on-
pump-beating heart technique. In our group there were
no conversions to cardioplegic arrest and aortic cross
clamping. The mean number of graft/patient was 2.9 ± 0.6
and the left internal mammary artery (LIMA) was used 23
times (92%). In two cases the mammary artery was not
used because the time spent to harvest the mammary
artery would have endangered the patient's hemodynamic
stability, and in one case both mammary arteries were pre-
pared due to a previous bilateral safenectomy. The left
anterior descending coronary artery (LAD) was revascular-
ized in all 25 patients (100%), one or more marginal
branches from the circumflex coronary artery were grafted
in 20 patients (82%) and a branch from the right coronary
artery was revascularized in 22 cases (88%). The myocar-
dial revascularization was complete for 23 patients
(92%). The mean CPB time was 84 ± 19 minutes and the
mean total operative time was 188 ± 36 minutes (intraop-
erative data are listed in Table 3).
Two patients (8%) died during recovery in the Intensive
Care Unit: the first one died following major and irrevers-
ible ventricular fibrillation one day after the procedure
and the second patient died following mediastinitis and
sepsis two weeks after the operation. Among the 23 survi-
vors, no one developed a postoperative acute myocardial
infarction and the mean CK peak rate was 1060 ± 1094 U/
l, in line with the preoperative diagnosis of severe coro-
nary syndrome and acute myocardial infarction. The
intensive use of heparin, aspirin, clopidogrel and IIb/IIIa
receptors' inhibitors before surgery, can explain a mean
postoperative bleeding of 1340 ± 903 mL. Although, the
surgical bleeding was diffuse and continuous, each
patient's hemodynamic stability was never compromised,
they all received fresh plasma and platelets if needed, and
there were no re-thoracotomies for bleeding or for any
other reason in our series. A transitory postoperative renal
failure was also diagnosed in eight patients during recov-
ery in the ICU and this was probably due to preoperative
low cardiac output syndrome. The mean Intensive Care
Unit stay was 4.4 ± 6.4 days and the mean global hospital
stay was 12 ± 6.7 days (see Table 4). Before being dis-
charged from the hospital, the 23 patients having survived
surgery underwent a trans-thoracic echocardiogram show-
ing a mean LVEF of 34.4 ± 8.5%.
Table 1: Baseline patient profile*
No. of Patients 25
Age (years) 69 ± 7 (range 57–79)
Gender (M/F) 18/7
CCS angina class
I 0 (0%)
II 4 (16%)
III 13 (53%)
IV 8 (31%)
LVEF (%) 27 ± 8
Hypertension 14 (56%)
Smoke 16 (65%)
Hypercholesterolemia 17 (70%)
Diabetes mellitus (I&II) 4 (16%)
Peripheral vascular disease 9 (35%)
Prior myocardial infarction 13 (53%)
Myocardial infarction < 7 days 9 (35%)
Urgency 2 (8%)
Emergency 23 (92%)
Preoperative IABP 7 (28%)
Preoperative mechanical ventilation 5 (20%)
Severe low cardiac output 9 (35%)
Left main stump disease 6 (24%)
3 – Vessel disease 22 (88%)
* Data are presented as mean ± SD or N (%)
CCS: Canadian Cardiovascular Society Angina Class; New York Heart 
Association; LVEF: Left Ventricular Ejection Fraction; MI: Myocardial 
Infarction; IABP: Intra-Aortic Balloon Pump.
Table 2: Preoperative risk profile according to the Euroscore.
Preoperative Euroscore Number of Patients, n (%)
6 3 (11%)
7 4 (16%)
8 5 (20%)
> 8 13 (53%)Page 3 of 6
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gery (mean follow-up time 14 ± 5 months): they all had a
standard trans-thoracic echocardiogram and a clinical
examination. Excluding one patient who died following
cardiac arrest four months after the operation, all 21 sur-
vivors have an acceptable quality of life with a mean LVEF
of 36 ± 11.8%. There were no cardiac re-operations, major
neurological events or acute myocardial infarctions,
although two patients required an implantable cardiac
defibrillator (ICD) to prevent severe electrical dysfunc-
tions originating from their ischemic cardiomyopathy.
Follow-up details are listed in Table 5.
Discussion
The optimal treatment for patients presenting with unsta-
ble angina, acute coronary syndrome, onset of myocardial
infarction or severe left ventricular dysfunction and carry-
ing a diffuse multi-vessel coronary artery disease is still
controversial. Primary coronary angioplasty and systemic
thrombolysis have been identified as fast and efficient
treatments in case of severe and irreversible acute coro-
nary syndrome but they can also be contraindicated,
depending on specific concomitant factors. In particular,
patients with severe multivessel coronary artery disease or
main stump disease, presenting comorbidities that con-
traindicate the thrombolysis, or showing signs of acute
and severe left ventricular dysfunction with low cardiac
output requiring urgent mechanical circulatory support,
can derive big benefits from emergency on-pump multi-
ple myocardial revascularization. Nevertheless, the stand-
ard surgical technique, with cardioplegic arrest and
cardiopulmonary bypass, may not be the ideal solution in
this cohort of very high-risk and unstable patients: in par-
ticular, cardioplegic arrest and aortic cross clamping have
been isolated as independent surgical risk factors for high-
risk patients suffering from acute coronary syndrome and
severe cardiac dysfunction, while the avoidance of cardi-
opulmonary bypass does not confer significant clinical
advantages, as suggested by recent reports [10,11]. In par-
ticular, the report from Légaré et Al [11], in which two
groups of patients undergoing CABG with CPB or on the
beating heart are compared, does not demonstrate any
difference between the two groups, with regards to post-
operative mortality, morbidity and hospital stay length.
Following those findings and in order to guarantee the
best surgical results in this restricted group of patients, the
beating heart technique for emergency CABG can be sup-
ported by the use of appropriate technical supports, like
intra-aortic balloon pump, heart stabilizers, intra-coro-
nary shunts and complete CPB [2-12]. In other words, in
order to achieve a maximum long-term benefit while min-
imizing short-term risks, further surgical strategies have
been recently explored and the on-pump beating heart
coronary surgery has been reported as an acceptable trade-
off between the conventional CABG with cardioplegic
arrest and the OPCABG in selected unstable high-risk
patients and in emergencies [13-15]. In our report we
present the one year follow-up after multiple myocardial
revascularizations under on-pump beating heart tech-
nique, in a series of 25 consecutive very high risk patients
operated in emergency, out of 290 patients operated in
the same period for standard CABG. In particular, our
patients were not suitable for alternative non-surgical
treatments, they were operated in the shortest delay, and
they were preoperatively treated with IABP and/or high
doses of inotropic drugs in order to achieve a certain
Table 3: Intraoperative data*
No. of Patients 25
No. of graft/patient 2.9 ± 0.6
Use of LIMA 22 (88%)
Use of LIMA + RIMA 1 (4%)
Use of veins 25 (100%)
Target Coronary Arteries:
Left anterior descending artery 25 (100%)
Diagonal branches 3 (12%)
Marginal branches or Circumflex 20 (82%)
Right coronary artery 22 (88%)
Complete revascularization 23 (92%)
Cardiopulmonary bypass time (min) 84 ± 19
Operative time (min) 188 ± 36
* Data are presented as mean ± SD or N (%)
LIMA: Left Internal Mammary Artery; RIMA: Right Internal Mammary 
Artery.
Table 4: Postoperative results*
No. of patients 25
Hospital mortality 2 (8%)
Ventilation time (hours) 26 ± 37 (range 7–168)
Intraoperative IABP 3 (11%)
Total bleeding (mL) 1340 ± 903
Re-exploration for bleeding 0
Myocardial infarction 0
CK-MB peak (U/l) 1060 ± 1094
Postoperative LVEF (%) 34.4 ± 8.5
Low cardiac output 2 (8%)
Transitory acute renal failure 8 (32%)
Sternal infection 1 (4%)
Intensive care unit stay (days) 4.4 ± 6.4 (range 1–21)
Hospital stay (days) 12 ± 6.7 (range 8–34)
* Data are presented as mean ± SD or N (%)
IABP: Intra-Aortic Balloon Pump; CK-MB: Creatine Kinase-MB; LVEF: 
Left Ventricular Ejection Fraction.
Table 5: Follow-up results*
Mean follow-up time (months) 14 ± 5
No. of patients 23
Internal cardiac defibrillator 2
Cardiac death 1
LVEF (%) 36 ± 11.8
* Data are presented as mean ± SD or N (%)
LVEF: Left Ventricular Ejection Fraction.Page 4 of 6
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gest benefits deriving from the on-pump beating heart
technique were the reduction of the hemodynamic insta-
bility caused by surgical manipulations, the absence of
global myocardial ischemia during aortic cross-clamping
time and the absence of reperfusion after cardioplegic
arrest. Despite some reports comparing the on-pump
beating heart technique versus the standard CABG having
already been published in literature [13-16], only a few of
them have focused their attention to the selected cohort of
emergency high-risk coronary patients [16,17]. In their
report, for example, Edgerton et Al [17] described a series
of 364 cases operated under on-pump beating heart tech-
nique and, among them, only 15 (4.1%) were classified as
emergencies. In our series (25 patients), 92% of patients
were operated in an emergency and, in 9 cases, there were
clinical signs of severe life threatening low cardiac output.
The Euroscore rate was equal or superior to eight 18 times.
As expected in such a very high-risk group of patients, they
often developed postoperative transitory acute renal fail-
ure (32%) or low cardiac output (8%) and two from 25
died during recovery in the intensive care unit (mortality
rate 8%). Moreover, the patients' postoperative bleeding
rate was higher than expected in a normal CABG group
and this fact can be easily explained by the extensive use
of high doses of heparin and anti-platelet drugs given pre-
operatively. The mean intensive care unit stay was also
longer (4.4 ± 6.4 days) than expected in a standard CABG
group and all of these findings are in line with compara-
ble data already present in literature. Despite the fact that
our cohort of patients requiring emergency on-pump
beating heart surgery for CABG is a small group and that
the results cannot be evaluated in the way they would
have been if coming from a larger cohort of patients, we
strictly believe that focused reports are still necessary to
identify the best surgical approach in this selected dis-
eased population. In our experience, the on-pump beating
heart surgery in emergencies was used as the last way to
save people from life-threatening symptoms and, to us,
this treatment can guarantee acceptable results. The one
year follow-up showed that the mean patients' left ventri-
cle ejection fraction rate increased from 26 ± 8% (preop-
erative data including patients with IABP and high doses
of inotropic drugs) to 36 ± 11.8% which is a good result
and let patients live acceptable lives. Unfortunately,
according to the presence of some degree of ischemic car-
diac myopathy in patients who survived surgery, one
patient died of irreversible ventricular fibrillation and two
patients required an implantable cardiac defibrillator.
In conclusion, one of the main problems in patients
undergoing emergency CABG remains the myocardial
protection and the side effects coming from the transitory
myocardial ischemia during arrested heart surgery (possi-
bly due to the myocardial edema) [18,19]. Theoretically,
off-pump beating heart surgery supported by inotropic
drugs and an aortic balloon pump can be a suitable solu-
tion for high-risk emergency CABG despite the fact that in
cases of cardiogenic shock the extensive mobilization and
manipulation of the heart can lead to severe hemody-
namic instability. In conclusion, although further reports
and randomized clinical trials are necessary to compare
results coming from different surgical strategies under-
taken to treat such a subgroup of high-risk patients, we
strongly believe that, following reported data and looking
closely to our surgical activity in this field, the on-pump
beating heart CABG surgery, when not strictly contraindi-
cated (i.e. calcified aorta), can lead to acceptable short and
mid-term results and remains an attractive alternative to
conventional myocardial revascularization and off-pump
beating heart surgery in emergency cases.
Study limitations
This clinical study is a non randomized retrospective
study followed by a one year follow-up. There is no con-
trol group because, during the observational period, all
patients suffering from acute coronary syndrome followed
by cardiac failure and referred to our department, were
immediately sent for surgery and operated under on-
pump beating heart technique. Moreover, the cohort of
patients involved in our study represents a small and
selected group of high-risk patients operated for CABG
during the observational period (the 8.6% of all CABG
cases). Although a bigger amount of patients would be
mandatory to guarantee more statistically significant
results coming from this surgical technique, we believe
that our study can already show interesting results in
terms of short-term and mid-term follow-up.
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